The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 10,628 | 1,455,904 | SH | SOLE | 1,455,904 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 5,970 | 1,356,813 | SH | SOLE | 1,356,813 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 19,195 | 1,599,592 | SH | SOLE | 1,599,592 | 0 | 0 | ||
| GLAUKOS CORP | COM | 377322102 | 218 | 3,362 | SH | SOLE | 3,362 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 8,596 | 388,766 | SH | SOLE | 388,766 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 23,034 | 1,074,316 | SH | SOLE | 1,074,316 | 0 | 0 | ||
| OBALON THERAPEUTICS INC | COM | 67424L100 | 9,591 | 3,552,239 | SH | SOLE | 3,552,239 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 78,868 | 2,021,738 | SH | SOLE | 2,021,738 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 109 | 8,293 | SH | SOLE | 8,293 | 0 | 0 | ||
| RESTORATION ROBOTICS INC | COM | 76133C103 | 15,532 | 5,355,786 | SH | SOLE | 5,355,786 | 0 | 0 | ||
| NEURONETICS INC | COM | 64131A105 | 33,044 | 1,030,689 | SH | SOLE | 1,030,689 | 0 | 0 | ||